2m 2m 2m 2m 2m 2m 2m
Embecta (EMBC)
NASDAQ
$3.11+$0.08 (+2.48%)
Price as of Jun 23, 2026 6:26 PM EDT- $179.8MMarket Cap
- -67.86%1-Year Change
- Medical Instruments & SuppliesIndustry
Embecta (EMBC)
$3.11+$0.08 (+2.48%)
Annual
Quarterly
09/30/2025 | 09/30/2024 | 09/30/2023 | 09/30/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 1.1B -3.80% | 1.1B +0.21% | 1.1B -0.77% | 1.1B N/A | |
Cost of Revenue | 403.6M +4.05% | 387.9M +4.58% | 370.9M +4.60% | 354.6M N/A | |
Gross Profit | 676.8M -7.94% | 735.2M -1.96% | 749.9M -3.23% | 774.9M N/A | |
Sales and Marketing Expense | 332.0M -9.07% | 365.1M +6.97% | 341.3M +15.77% | 294.8M N/A | |
Research and Development Expense | -37.3M -52.66% | -78.8M -7.51% | -85.2M -227.35% | 66.9M N/A | |
Depreciation and Amortization Expense | 40.7M +12.43% | 36.2M +11.04% | 32.6M +2.84% | 31.7M N/A | |
Total Operating Expenses | 434.7M -23.52% | 568.4M +7.57% | 528.4M +13.56% | 465.3M N/A | |
Operating Profit | 242.1M +45.14% | 166.8M -24.70% | 221.5M -28.46% | 309.6M N/A | |
Interest Income | 6.0M -50.00% | 12.0M +27.66% | 9.4M N/A | N/A N/A | |
Interest Expense | -107.3M -4.45% | -112.3M +4.95% | -107.0M +131.60% | -46.2M N/A | |
Interest Income and Expense and Net | -101.3M +1.00% | -100.3M +2.77% | -97.6M +111.26% | -46.2M N/A | |
Total Nonoperating Income and Expense | 1.5M +114.56% | -10.3M +17.05% | -8.8M +29.41% | -6.8M N/A | |
Income before Taxes | 136.3M +208.37% | 44.2M -58.18% | 105.7M -58.81% | 256.6M N/A | |
Income Taxes | 40.9M +219.94% | -34.1M -196.60% | 35.3M +6.97% | 33.0M N/A | |
Extraordinary Items | 0 N/A | 0 -100.00% | 2.5M -95.76% | 58.9M N/A | |
Net Income | 95.4M +21.84% | 78.3M +11.22% | 70.4M -68.52% | 223.6M N/A | |
Net Income from Continuing Operations Applicable to Common | 136.3M +208.37% | 44.2M -58.18% | 105.7M -58.81% | 256.6M N/A | |
Basic EPS and Net Income | 1.64 +20.59% | 1.36 +10.57% | 1.23 -68.62% | 3.92 N/A | |
Diluted EPS and Net Income | 1.62 +20.90% | 1.34 +9.84% | 1.22 -68.64% | 3.89 N/A | |
Basic Weighted Average Shares | 58.3M +1.09% | 57.7M +0.76% | 57.2M +0.39% | 57.0M N/A | |
Diluted Weighted Average Shares | 58.9M +1.01% | 58.3M +0.98% | 57.8M +0.52% | 57.5M N/A | |
Balance Sheet | |||||
Cash and Cash Equivalents | 225.5M -15.70% | 267.5M -18.07% | 326.5M -1.33% | 330.9M N/A | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 225.5M -15.70% | 267.5M -18.07% | 326.5M -1.33% | 330.9M N/A | |
Total Current Assets | 631.4M -17.03% | 761.0M +1.59% | 749.1M +12.70% | 664.7M N/A | |
Accumulated Depreciation | 534.1M +9.29% | 488.7M +9.16% | 447.7M +11.93% | 400.0M N/A | |
Property and Plant and Equipment and Net | 257.2M -11.43% | 290.4M -3.26% | 300.2M -0.46% | 301.6M N/A | |
Total Long-Term Assets | 85.0M -72.94% | 314.1M -3.32% | 324.9M -0.40% | 326.2M N/A | |
Total Assets | 1.1B -15.12% | 1.3B +5.84% | 1.2B +11.78% | 1.1B N/A | |
Income Taxes Payable | 9.8M -63.30% | 26.7M -20.54% | 33.6M +23.53% | 27.2M N/A | |
Total Short-Term Debt | 9.5M 0.00% | 9.5M 0.00% | 9.5M 0.00% | 9.5M N/A | |
Total Current Liabilities | 261.5M -30.08% | 374.0M +5.80% | 353.5M +17.44% | 301.0M N/A | |
Total Long-Term Debt | 1.4B -11.28% | 1.6B -1.79% | 1.6B -0.26% | 1.6B N/A | |
Total Long-Term Liabilities | 1.4B -11.28% | 1.6B -1.79% | 1.6B -0.26% | 1.6B N/A | |
Total Liabilities | 261.5M -30.08% | 374.0M +5.80% | 353.5M +17.44% | 301.0M N/A | |
Retained Earnings | -445.6M -10.63% | -498.6M -7.85% | -541.1M -6.24% | -577.1M N/A | |
Total Stockholders Equity | -650.6M -11.88% | -738.3M -10.15% | -821.7M -7.82% | -891.4M N/A | |
Total Shares Outstanding | 58.5M +1.37% | 57.7M +0.65% | 57.3M +0.49% | 57.1M N/A | |
Cash Flow | |||||
Cash from Operating Activities | 191.7M +436.97% | 35.7M -47.27% | 67.7M -83.58% | 412.2M N/A | |
Capital Expenditures | 9.3M -41.14% | 15.8M -40.38% | 26.5M +12.29% | 23.6M N/A | |
Cash from Investing Activities | -9.3M -41.14% | -15.8M -40.38% | -26.5M +10.42% | -24.0M N/A | |
Dividends Paid | 35.0M +1.45% | 34.5M +0.29% | 34.4M +300.00% | 8.6M N/A | |
Cash from Financing Activities | -226.7M +208.86% | -73.4M +50.72% | -48.7M +1.46% | -48.0M N/A | |
Financials Ratio | |||||
Gross Margin | 62.64% -4.31% | 65.46% -2.16% | 66.91% N/A | N/A N/A | |
Operating Margin | 22.41% +50.88% | 14.85% -24.85% | 19.76% N/A | N/A N/A | |
Return on Assets | 8.03% +28.17% | 6.26% +2.37% | 6.12% N/A | N/A N/A | |
Return on Equity | -13.74% +36.85% | -10.04% +22.14% | -8.22% N/A | N/A N/A | |
Revenue Growth | -3.80% -1,952.83% | 0.21% +126.64% | -0.77% N/A | N/A N/A | |
Current Ratio | 2.41 +18.66% | 2.03 -3.98% | 2.12 N/A | N/A N/A | |
Cash Ratio | 0.86 +20.57% | 0.72 -22.56% | 0.92 N/A | N/A N/A | |
Debt-to-Equity Ratio | -2.15 +0.75% | -2.13 +9.31% | -1.95 N/A | N/A N/A | |
Debt-to-Assets Ratio | 1.28 +4.61% | 1.23 -7.20% | 1.32 N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow